A Phase II Trial of ZD1839 (Iressa) (NSC 715055) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2013
At a glance
- Drugs Gefitinib (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Pharmacogenomic; Therapeutic Use
- 04 Nov 2008 Checked against ClinicalTrials.gov record.
- 10 Sep 2005 New trial record.